Altman Z-Score
6.06
-0.16-2.57%
2 min ago
Summary
- As of February 7, 2025, CRSP Altman Z-Score is 6.06, with the most recent change of -0.16 (-2.57%) on February 7, 2025.
- CRSP current Altman Z-Score indicates the stock has a low bankruptcy risk.
Performance
CRSP Altman Z-Score Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Altman Z-Score Formula
Z-Score = 1.2*A + 1.4*B + 3.3*C + 0.6*D + 1.0*E- A = Working Capital / Total Assets
- B = Retained Earnings / Total Assets
- C = EBIT / Total Assets
- D = Market Cap / Total Liabilities
- E = Revenue / Total Assets
- A = Working Capital / Total Assets
- B = Retained Earnings / Total Assets
- C = EBIT / Total Assets
- D = Market Cap / Total Liabilities
- E = Revenue / Total Assets
CRSP Altman Z-Score Trends
PeriodPeriod | Altman Z-ScoreAltman Z-Score | PricePrice | Market capMarket cap |
---|---|---|---|
todaytoday | -2.6% | -2.6% | -2.6% |
1 m1 month | -5.6% | -5.7% | -5.7% |
3 m3 months | -23.2% | -23.7% | -23.7% |
6 m6 months | -15.4% | -15.9% | -15.8% |
ytdytd | +1.2% | +1.3% | +1.3% |
1 y1 year | -34.8% | -39.5% | -35.5% |
5 y5 years | -62.5% | -23.8% | +6.8% |
CRISPR Therapeutics AG Altman Z-Score History
Date | Value |
---|---|
2025 | 6.06(+1.2%) |
2024 | 5.99(-32.5%) |
2023 | 8.87(+86.3%) |
2022 | 4.76(-59.0%) |
2021 | 11.62(-72.0%) |
Date | Value |
---|---|
2020 | 41.46(+122.8%) |
2019 | 18.61(+122.6%) |
2018 | 8.36(+26.7%) |
2017 | 6.60(+32.3%) |
2016 | 4.99 |
FAQ
- What is CRISPR Therapeutics AG altman z-score?
- What is CRSP altman z-score year-to-date change?
- What is CRISPR Therapeutics AG altman z-score year-on-year change?
What is CRISPR Therapeutics AG altman z-score?
The current altman z-score of CRSP is 6.06
What is CRSP altman z-score year-to-date change?
CRISPR Therapeutics AG altman z-score has changed by +0.07 (+1.17%) since the beginning of the year
What is CRISPR Therapeutics AG altman z-score year-on-year change?
Over the past year, CRSP altman z-score has changed by -3.24 (-34.84%)